...
首页> 外文期刊>Clinical infectious diseases >Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
【24h】

Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.

机译:乳酸奈瑟菌在鼻咽部定植并诱导针对脑膜炎奈瑟菌的保护性免疫。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Natural immunity to Neisseria meningitidis may result from nasopharyngeal carriage of closely related commensals, such as Neisseria lactamica. METHODS: We enrolled 61 students with no current carriage of Neisseria species and inoculated them intranasally with 10,000 colony-forming units of Neisseria lactamica or sham control. Colonization was monitored in oropharyngeal samples over 6 months. We measured specific mucosal and systemic antibody responses to N. lactamica and serum bactericidal antibody (SBA) and opsonophagocytic antibodies to a panel of N. meningitidis serogroup B strains. We also inoculated an additional cohort following vaccination with N. lactamica outer-membrane vesicles (OMV) produced from the same strain. RESULTS: Twenty-six (63.4%) of 41 inoculated individuals became colonized with N. lactamica; 85% remained colonized at 12 weeks. Noncarriers were resistant to rechallenge, and carriers who terminated carriage were relatively resistant to rechallenge. No carriers acquired N. meningitidis carriage over 24 weeks, compared with 3 control subjects (15%). Carriers developed serum IgG and salivary IgA antibodies to the inoculated N. lactamica strain by 4 weeks; noncarriers and control subjects did not. Cross-reactive serum bactericidal antibody responses to N.meningitidis were negligible in carriers, but they developed broad opsonophagocytic antimeningococcal antibodies. OMV vaccinees developed systemic and mucosal anti-N. lactamica antibodies and were relatively resistant to N. lactamica carriage but not to natural acquisition of N. meningitidis. CONCLUSIONS: Carriers of N. lactamica develop mucosal and systemic humoral immunity to N. lactamica together with cross-reacting systemic opsonophagocytic but not bactericidal antibodies to N. meningitidis. Possession of humoral immunity to N. lactamica inhibits acquisition of N. lactamica but not of N. meningitidis. Some individuals are intrinsically resistant to N. lactamica carriage, independent of humoral immunity.
机译:背景:对脑膜炎奈瑟菌的天然免疫力可能是由鼻息肉携带着密切相关的食物,如乳酸奈瑟氏菌。方法:我们招募了61名目前没有携带奈瑟氏菌物种的学生,并向他们鼻内接种了10,000个内生奈瑟氏菌或假手术对照的菌落形成单位。在6个月内监测口咽样品中的定植。我们测量了对内酰胺N.乳球菌和血清杀菌抗体(SBA)的特异性粘膜和全身抗体反应以及对一组脑膜炎双球菌B血清群菌株的调理吞噬抗体。我们还接种了由同一菌株产生的内酰胺猪笼草外膜囊泡(OMV)进行接种的另一个队列。结果:41名接种者中有26名(占63.4%)被内酰胺乳杆菌定殖。 12周时仍有85%的菌落。非承运人对再挑战具有抵抗力,终止运输的承运人对再挑战具有相对抵抗力。与3名对照受试者(15%)相比,没有携带者在24周内获得了脑膜炎奈瑟氏球菌运输。到4周时,携带者对已接种的乳酸奈瑟菌菌株产生了血清IgG和唾液IgA抗体。非携带者和对照组则没有。在携带者中对脑膜炎奈瑟菌的交叉反应血清杀菌抗体反应可忽略不计,但它们开发了广泛的调理吞噬抗脑膜炎球菌抗体。 OMV疫苗开发了全身性和粘膜抗N抗体。内酰胺酶抗体,对内酰胺猪笼草运输相对抗性,但对脑膜炎奈瑟球菌的自然采集不产生抗性。结论:乳酸链球菌的载体与交叉反应的全身性调理吞噬细胞一起发展出对乳酸杆菌的粘膜和全身性体液免疫,但对脑膜炎双球菌却没有杀菌抗体。对乳酸杆菌的体液免疫的拥有抑制了乳酸杆菌的获得,但不抑制脑膜炎奈瑟氏菌的获得。一些个体固有地抵抗内酰胺猪笼草运输,独立于体液免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号